Zdrowie i gospodarka · 09/01/2024
FDA Announces Public Comment Period for Expedited Programs for Serious Conditions-Drugs and Biologics
The Food and Drug Administration (FDA) is seeking public comment on its proposed collection of information related to Expedited Programs for Serious Conditions-Drugs and Biologics, as required by the Paperwork Reduction Act of 1995.